Sanofi's Merilog wins FDA approval as the first rapid-acting insulin biosimilar to Novolog, offering a new option for diabetes management.
According to the FDA, the medication quickly helps to lower mealtime blood sugar spikes to improve control of blood sugar in ...
The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...
The US Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart), ...
The U.S. Food and Drug Administration (USFDA) on Friday approved Merilog as biosimilar to Novolog (insulin aspart) for the ...
Three Blue Mountains residents have received their results from PFAS blood testing, prompting demands for a community-wide ...
Mariposa California's original daily updated online newspaper is the premier site for news and information on Yosemite, ...
Ingelheim, Germany Saturday, February 15, 2025, 12:00 Hrs [IST] ...
The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...
Merilog’s approval comes as the insulin space has over the past year suffered several setbacks, including strong calls for ...
A nurse-led mobile healthcare clinic identified a high proportion of clinically significant prostate cancers among men from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results